Nuclein, LLCAmended
Biotechnology · AUSTIN, TX
BiotechnologySEC Form D
Nuclein, LLC filed a Form D with the U.S. Securities and Exchange Commission on April 27, 2026, reporting $19,065,157 raised toward a $25,000,000 offering.
Incorporated in Texas and based in AUSTIN, TX, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Nuclein, LLC has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Alan BlakeExecutive Officer · Director
- Richard CrockettDirector
- William CunninghamDirector
- Douglas BryantDirector
- Sanjay ChandraDirector
- H. David ShockleyDirector
- Walter NarajowskiDirector
- Jeffrey StukulsExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised